Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
How Large Is the Point Of Care Hematology Diagnostics Market Expected to Be in 2029?
There has been substantial growth in the size of the point of care hematology diagnostics market in recent times, with projections showing an increase from $2.66 billion in 2024 to $2.90 billion in 2025, suggesting a compound annual growth rate (CAGR) of 9.1%. The historical growth can be linked to factors like the increasing incidence of hematological disorders, the emergence of decentralized healthcare facilities, an amplified emphasis on early detection of diseases, increased healthcare spending in developing markets, and the rising utilization of portable diagnostic devices.
The market size of point of care hematology diagnostics is projected to experience significant expansion in the coming years, estimated to reach $4.05 billion by 2029 with a compound annual growth rate (CAGR) of 8.7%. This anticipated growth in the forecast period is due to factors such as the increased uptake of personalized medicine, the rising demand for immediate clinical decisions and home healthcare diagnostics, an escalated prevalence of blood-related disorders, and heightened awareness surrounding preventive healthcare. Key trends expected during the forecast span incorporate advancements in hematology analyzer connectivity features, improvements in sample preparation approaches, the incorporation of artificial intelligence into diagnostic instruments, developments in single-cell analysis techniques, the integration of cloud-based data platforms, and progressions in lab-on-a-chip solutions.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=27388&type=smp
What Are The Contributors To Demand In The Point Of Care Hematology Diagnostics Market?
The escalation in the occurrence of blood disorders is set to fuel the expansion of the point-of-care hematology diagnostics market in the future. Blood disorders encompass those ailments that disturb the constituents of blood such as red blood cells, white blood cells, platelets, or plasma. The primary cause of this rise in blood disorders is the mounting prevalence of chronic maladies that gravely affect the health of the blood and necessitate continuous tracking. The point-of-care hematology diagnostics offer prompt and precise results at or near the patient care site, thereby facilitating speedy clinical judgments and better disease administration. For example, the Perth Blood Institute, a non-profit entity based in Australia reported that in April 2024, people diagnosed with hemophilia, a hereditary blood disorder characterized by the blood’s inability to clot properly leading to extended bleeding, edged up to 257,146 in 2022 from 233,577 in 2021. Consequently, the escalating occurrence of blood disorders is driving the point-of-care hematology diagnostics market’s expansion.
What Segmentation Categories Are Included In The Point Of Care Hematology Diagnostics Market Analysis?
The point of care hematology diagnostics market covered in this report is segmented
1) By Type: Complete Blood Count, Coagulation Testing, Hemoglobin Testing, Anemia Diagnosis, Other Types
2) By Product: Consumables, Systems
3) By Mode Of Prescription: Prescription Based Product, Over-The-Counter Based Product
4) By End User: Diagnostic Centers, Hospitals, Blood Banks, Transfusion Centers, Other End Users
Subsegments:
1) By Complete Blood Count: White Blood Cell Count, Red Blood Cell Count, Platelet Count, Hematocrit, Hemoglobin Concentration, Mean Corpuscular Volume (MCV)
2) By Coagulation Testing: Prothrombin Time (PT), Activated Partial Thromboplastin Time (aPTT), International Normalized Ratio (INR), D-Dimer Test, Fibrinogen Level
3) By Hemoglobin Testing: Total Hemoglobin, Glycated Hemoglobin (HbA1c), Oxyhemoglobin, Carboxyhemoglobin, Methemoglobin
4) By Anemia Diagnosis: Iron Studies, Vitamin B12 Levels, Folate Levels, Reticulocyte Count, Ferritin Test, Transferrin Saturation
5) By Other Types: Blood Typing And Crossmatching, Erythrocyte Sedimentation Rate, Malaria Parasite Detection, Sickle Cell Screening, C-Reactive Protein Testing
What Upcoming Trends Are Expected To Impact The Point Of Care Hematology Diagnostics Market Globally?
Leading entities in the point-of-care hematology diagnostics market are working towards creating products that are technologically superior, such as AI-powered hematology analyzers that use cartridges, with the aim to provide quick, precise, and local blood analysis for enhanced patient care. These cartridge-based AI-powered hematology analyzers are compact diagnostic tools that employ single-use reagent cartridges and artificial intelligence algorithms to effectively and correctly analyze blood samples at the care location. For instance, Zoetis Inc., a veterinary health firm based in the US, introduced Vetscan OptiCell, an AI-powered hematology analyzer that utilizes cartridges, specifically for veterinary usage in September 2024. This revolutionary system provides swift, reference laboratory-grade complete blood count (CBC) results within minutes at the point of care, while also reducing maintenance and time spent on it. It comes with state-of-the-art AI-controlled image analysis and viscoelastic focusing technology that accurately aligns cells for clear imaging, thus enabling precise blood cell categorization and automated anomaly detection, ensuring efficient and trustworthy veterinary diagnostics.
Who Are The Top-Ranked Companies In The Point Of Care Hematology Diagnostics Market Today?
Major companies operating in the point of care hematology diagnostics market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Shenzhen Mindray Bio-Medical Electronics Co. Ltd., Sysmex Corporation, HORIBA Ltd., Nova Biomedical Corp., S.D. Sight Diagnostics Ltd., EKF Diagnostics Holdings plc., Medsource Ozone Biomedicals Pvt. Ltd., BioSystems S.A., Chengdu Seamaty Technology Co. Ltd., Drucker Diagnostics LLC, Diamond Diagnostics Inc., DIAGON Kft., BioMedomics Inc., Norma Instruments Zrt., PixCell Medical Technologies Ltd.
Get The Full Report Here:
How Is Point Of Care Hematology Diagnostics Market Adoption Varying Across Different Regions And Sectors?
North America was the largest region in the point of care hematology market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the point of care hematology diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/customise?id=27388&type=smp
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model